New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A3675

Introduced
1/13/26  
Refer
1/13/26  
Failed
1/13/26  

Caption

Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.

Impact

By allowing pharmacists to dispense PrEP and PEP without individual prescriptions, A3675 is likely to have a significant impact on HIV prevention efforts in New Jersey. It addresses potential gaps in healthcare access for patients who might otherwise face delays or obstacles in obtaining these medications through traditional healthcare avenues. Additionally, the requirement for health plans to cover these medications without prior authorization is expected to facilitate better health outcomes by encouraging more individuals at risk to seek preventive treatment. This change is anticipated to enhance public health initiatives surrounding HIV and AIDS prevention.

Summary

Assembly Bill A3675 seeks to expand access to HIV preventive measures by authorizing pharmacists to dispense both preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) without the need for an individual prescription under certain conditions. This legislative intent is aimed at reducing barriers for individuals who may require quick access to these medications, particularly in urgent situations where potential exposure to HIV has occurred. The bill mandates that health benefit plans cover these medications without imposing prior authorization or step therapy requirements, thereby streamlining the process for patients seeking these essential drugs.

Contention

However, the bill may face contention regarding the implications for pharmacists’ roles and responsibilities, as well as potential concerns over monitoring and documentation for patients receiving these medications without a prescription. Critics may argue about the adequacy of training provided to pharmacists under the proposed legislation, and whether sufficient safeguards are in place to ensure proper patient evaluations. Moreover, debates could also arise around the potential economic impact on health insurance providers, especially if the number of claims increases significantly due to the broader availability of PrEP and PEP.

Companion Bills

NJ S2019

Carry Over Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.

NJ A3089

Carry Over Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.

NJ S2586

Same As Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.

Similar Bills

NJ S2586

Authorizes pharmacists to dispense HIV prophylaxis without individual prescription under certain circumstances; mandates prescription benefits coverage.

CA AB602

Public postsecondary education: student behavior: drug and alcohol use: rehabilitation programs.

CA AB554

Health care coverage: antiretroviral drugs, drug devices, and drug products.

CA SB1023

Health care coverage: antiretroviral drugs, drug devices, and drug products.

GA SB195

Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; provide

KS HB2100

Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.

NY S07435

Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.

AZ HB2444

Pharmacists; independent testing; treatment